DermatologyResearch Phase

Haloxyl (Chrysin + Palmitoyl Peptides)

Overview

Haloxyl is a combination ingredient consisting of chrysin, a naturally occurring flavone, and palmitoyl oligopeptides designed to address periorbital hyperpigmentation and edema. The chrysin component is thought to activate enzyme systems involved in bilirubin and hemoglobin clearance, while the palmitoyl peptides enhance dermal penetration and stimulate lymphatic drainage. This dual-mechanism approach targets the appearance of dark circles attributable to both vascular congestion and iron deposition.

Key Research Findings

Manufacturer-sponsored studies reported reductions in periorbital pigmentation and puffiness assessed by chromametry and clinical grading, though independent replication in peer-reviewed dermatology literature is limited. The evidence base consists primarily of in vitro permeability studies and small open-label human trials without published long-term safety data.

Route of Administration

Topical

Regulatory Status

Research Phase

Interested in Haloxyl (Chrysin + Palmitoyl Peptides)?

Find a verified provider experienced with Haloxyl (Chrysin + Palmitoyl Peptides) protocols in your area. All providers are credentialed and use compliant sourcing.

Find a Haloxyl (Chrysin + Palmitoyl Peptides) Provider

Related Peptides

Afamelanotide (Scenesse)

FDA Approved

A synthetic 13-amino acid analog of alpha-melanocyte-stimulating hormone (alpha-MSH) with a substitution of norleucine at position 4 that confers enhanced potency and enzymatic stability. Afamelanotide activates melanocortin-1 receptors (MC1R) on melanocytes, stimulating eumelanin production independent of UV exposure. The resulting increase in skin eumelanin provides photoprotection by absorbing UV radiation and scavenging reactive oxygen species.

Argireline (Acetyl Hexapeptide-8)

Investigational

Argireline is a synthetic six amino acid peptide (Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2) designed to attenuate neurotransmitter release at the neuromuscular junction. It functions as a competitive inhibitor of the SNARE complex, reducing catecholamine release and potentially diminishing muscle contraction intensity in facial expression muscles. This mechanism provides a topical alternative rationale to botulinum toxin for addressing expression lines, though with markedly lower potency.

Matrixyl (Palmitoyl Pentapeptide-4)

Investigational

Matrixyl is a lipopeptide composed of a pentapeptide sequence (Lys-Thr-Thr-Lys-Ser) attached to a palmitic acid moiety to enhance dermal penetration. It is proposed to stimulate fibroblast activity and upregulate synthesis of extracellular matrix components including collagen types I and III, fibronectin, and hyaluronic acid. The peptide serves as a matrikine fragment mimetic, signaling tissue remodeling pathways in aged or photodamaged skin.

Matrixyl 3000

Investigational

Matrixyl 3000 is a proprietary combination of two lipopeptides: palmitoyl tripeptide-1 (Pal-GHK) and palmitoyl tetrapeptide-7 (Pal-GQPR). The formulation is designed to synergistically promote collagen and fibronectin synthesis while reducing interleukin-6 mediated inflammation in dermal fibroblasts. Both peptides carry palmitic acid for enhanced lipid solubility and stratum corneum permeation.